G6PD and malaria: In a more recent study conducted in 2045 samples obtained from six African populations (Burkina Faso, Ghana, Kenya, Nigeria, Tanzania, Mali) with acute uncomplicated falciaprum malaria [44], G6PD genotype or phenotype had no influence on anti-malarial efficacy of combination therapy with artemether-lumefantrine and chlorproguanil-dapsone-artesunate.